Immunotherapy
Entity.
- Evidence
- 513 documents · 141 separate publishers
- Standing
- We keep this record by hand
- Time
- first seen 1 Jan 2026, last seen 5 Oct 2026
- Measured
- 17% of mentions say something specific about it; the rest only name it
- As of
- 6 Oct 2026
Where this comes from
- Frontiers Precision Oncology · 2026-10-05 · Editorial: Evolving non-invasive biomarkers: chemokines and multi-omic profiling in NSCLC immunotherapy response (opens the source in a new tab)
- Seoul Economic Daily - English Edition · 2026-10-02 · Korean Surgeons See Shift to Pre-Surgery Immunotherapy in Stage 2-3 Stomach Cancer (opens the source in a new tab)
- J Control Release · 2026-10-02 · A systemic-absorption-blocked (SEAL) nanoplatform for mRNA-based local immunotherapy. (opens the source in a new tab)
- News from California, across the nation and world - Los Angeles Times · 2026-10-01 · Your guide to Proposition 38: Immunology and immunotherapy research funding (opens the source in a new tab)
- Future Oncol · 2026-10-01 · SUNRAY-02: a study of olomorasib combined with immunotherapy in stage II-III KRAS G12C-mutant non-small cell lung cancer after definitive therapy. (opens the source in a new tab)
- J Immunother Cancer · 2026-10-01 · Propionate promotes CD8+ T-cell infiltration and enhances immunotherapy efficacy in colorectal cancer. (opens the source in a new tab)
- Cell Host Microbe · 2026-09-30 · An enzyme-responsive nanoplatform rewires host-microbe tryptophan metabolism for cancer immunotherapy. (opens the source in a new tab)
- The Medical News · 2026-09-29 · Blood tests can identify cancer neoantigens for personalized immunotherapy (opens the source in a new tab)
- Cancer Sci · 2026-09-28 · SLAMF6 Enhances the Efficacy of Anti-PD-L1 Immunotherapy in CRC Through the STAT1/CXCL10 Signaling Axis. (opens the source in a new tab)
- The ASCO Post · 2026-09-28 · Adding Targeted Immunotherapy to Pembrolizumab in Recurrent or Metastatic HPV16-Positive Head and Neck Squamous Cell Carcinoma (opens the source in a new tab)
- Frontiers Precision Oncology · 2026-09-25 · Case Report: Conversion therapy with chemotherapy, antiangiogenic therapy, and immunotherapy for locally advanced synchronous gastric hepatoid adenocarcino… (opens the source in a new tab)
- CRC Research (Google News) via Google News · 2026-09-25 · Ancient Herbal Formulas May Hold the Key to Unlocking Immunotherapy for Hard-to-Treat Colorectal Cancer - bioengineer.org (no link on file)
What is claimed about it
- Single source: Reported by one source so far.
- Propionate promotes CD8+ T-cell infiltration and enhances immunotherapy efficacy in colorectal cancer Single source · first reported 1 Oct 2026